Loading…
VivoSim Labs, Inc. is projected to decline to $0.2733 by 2027, a -18% move from its current price of $0.3346. VIVS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.3109 | $0.3347 | $0.3603 | +0.02% |
| Aug 6 | $0.3016 | $0.3347 | $0.3715 | +0.04% |
| Aug 7 | $0.2946 | $0.3348 | $0.3804 | +0.06% |
| Aug 8 | $0.2889 | $0.3349 | $0.3881 | +0.08% |
| Aug 9 | $0.284 | $0.3349 | $0.395 | +0.10% |
| Aug 10 | $0.2796 | $0.335 | $0.4013 | +0.11% |
| Aug 11 | $0.2756 | $0.335 | $0.4073 | +0.13% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.2756 | $0.335 | $0.4073 | +0.13% |
| Week 2 | $0.2546 | $0.3355 | $0.4421 | +0.27% |
| Week 3 | $0.2396 | $0.3359 | $0.4711 | +0.40% |
| Week 4 | $0.2277 | $0.3364 | $0.497 | +0.54% |
| Week 5 | $0.2177 | $0.3368 | $0.5211 | +0.67% |
| Week 6 | $0.2091 | $0.3373 | $0.544 | +0.81% |
| Week 7 | $0.2015 | $0.3377 | $0.566 | +0.94% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
VivoSim Labs, Inc. is a healthcare company focused on pharmaceutical and biotechnology services. It provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine, offering liver and intestinal toxicology insights through NAM models and bespoke services in investigational toxicology and mechanism of action elucidation, among other applications of complex human tissue models.
The company also develops 3D human tissue platforms that create normal and disease models using high throughput systems, bioprinting, and flow/stretch capable 3D systems. It was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc.
in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
VivoSim Labs, Inc. (VIVS) currently trades at $0.3446 per share with a market cap of $1.2M, ranking 5483. These figures place the company in the micro-cap tier within the Healthcare sector.
The price action shows a quiet near-term path, with a neutral technical posture and limited upside momentum ahead. The long-range outlook points to a potential rise toward higher price levels by 2050, supported by a forecast sequence that envisions meaningful upside over time.
A major level 1.6% above — losing it would weaken the trend.
Price is testing support right now (1.6% away) — a key level to hold.
The nearest ceiling, 237.7% above — a clean break opens room to run.
A major ceiling 411.1% above — clearing it would confirm fresh momentum.
Key VIVS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VIVS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.368 | Sell | $0.3766 | Sell |
| MA 10 | $0.412 | Sell | $0.4417 | Sell |
| MA 20 | $0.6075 | Sell | $0.5847 | Sell |
| MA 50 | $0.9564 | Sell | $0.8805 | Sell |
| MA 100 | $1.25 | Sell | $1.19 | Sell |
| MA 200 | $1.70 | Sell | $1.68 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 21.35 | Buy |
| Stoch RSI (14) | 28.32 | Neutral |
| CCI (20) | -89.95 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -60.00 | Sell |
| Bollinger %B (20,2) | 0.19 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -2.79 | Sell |
| Awesome (5,34) | -0.44 | Sell |
| Ultimate (7,14,28) | 20.02 | Buy |
| Momentum (10) | -0.24 | Sell |
| Aroon Osc (25) | -88.00 | Sell |
| Hull MA (9) | 0.34 | Sell |
| ADX (14) | 50.34 | Sell |
| ATR (14) | 0.04 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 20. The stock sits below the SMA200 ($1.70) and near the SMA50 ($0.9564), signaling limited near-term momentum. Key near-term support is at $0.34 and resistance at $1.13, creating a wide range for price movement over the next month.
The 30-day range spans from $0.2119 to $0.5604, highlighting notable volatility within a narrow band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.3346 | $0.3346 | $0.4737 | 0% | Neutral | |
| $0.1992 | $0.2733 | $0.4053 | -18% | Bearish | |
| $0.2202 | $0.3214 | $0.5086 | -4% | Neutral | |
| $0.3172 | $0.4879 | $0.8112 | +46% | Bullish | |
| $0.2734 | $0.4409 | $0.7634 | +32% | Bullish | |
| $0.2496 | $0.4209 | $0.7546 | +26% | Bullish | |
| $0.2318 | $0.4077 | $0.7539 | +22% | Bullish | |
| $0.1794 | $0.3285 | $0.6245 | -2% | Neutral | |
| $0.2292 | $0.4367 | $0.8512 | +31% | Bullish | |
| $0.2738 | $0.5423 | $1.08 | +62% | Bullish | |
| $0.2359 | $0.5242 | $1.15 | +57% | Bullish | |
| $0.5067 | $1.13 | $2.59 | +237% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.3346 | $0.3346 | $0.442 | +0.00% |
| September 2026 | $0.288 | $0.3501 | $0.444 | +4.64% |
| October 2026 | $0.2762 | $0.3405 | $0.4406 | -2.75% |
| November 2026 | $0.2874 | $0.3583 | $0.4713 | +5.24% |
| December 2026 | $0.2818 | $0.355 | $0.4737 | -0.92% |
Click any year to see its month-by-month VIVS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The VIVS price prediction for 2026 points to an average of $0.3346 (low $0.3346, high $0.4737) — a potential gain of 0% on today's $0.3346. A consolidation phase looks the most probable path here.
In 2027, VIVS is projected to trade between $0.1992 and $0.4053, averaging $0.2733 — a potential decline of -18% from today's $0.3346. That is -18% versus the projected 2026 average. A cyclical pullback looks likely — prices rarely move in a straight line.
VivoSim Labs, Inc.'s 2028 outlook centres on $0.3214, within a $0.2202 to $0.5086 range. That is up +18% on the projected 2027 average. That marks a -4% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, VIVS could reach as high as $0.8112, with a base case around $0.4879 and support toward $0.3172 — roughly +46% from $0.3346. Momentum favours further upside here.
Expect VIVS to range from $0.2734 to $0.7634 through 2030. The $0.4409 average target implies a +32% move from current prices. That is -10% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
The VIVS price prediction for 2031 points to an average of $0.4209 (low $0.2496, high $0.7546) — a potential gain of +26% on today's $0.3346. Momentum favours further upside here.
In 2032, VIVS is projected to trade between $0.2318 and $0.7539, averaging $0.4077 — a potential gain of +22% from today's $0.3346. That is -3% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
VivoSim Labs, Inc.'s 2033 outlook centres on $0.3285, within a $0.1794 to $0.6245 range. That is -19% versus the projected 2032 average. That marks a -2% change versus current levels. Price action looks broadly range-bound.
By 2034, VIVS could reach as high as $0.8512, with a base case around $0.4367 and support toward $0.2292 — roughly +31% from $0.3346. Buyers look set to stay in control over this stretch.
Expect VIVS to range from $0.2738 to $1.08 through 2035. The $0.5423 average target implies a +62% move from current prices. That is up +24% on the projected 2034 average. Momentum favours further upside here.
The VIVS price prediction for 2040 points to an average of $0.5242 (low $0.2359, high $1.15) — a potential gain of +57% on today's $0.3346. Buyers look set to stay in control over this stretch.
In 2050, VIVS is projected to trade between $0.5067 and $2.59, averaging $1.13 — a potential gain of +237% from today's $0.3346. That is up +115% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in VIVS today (≈ 2,988.643156 VIVS) could be worth
$3,365.37
+$2,365.37 (+237%) by 2050 · US Dollar
Based on the average projected VIVS price of $1.13 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VIVSwould be worth at today's price.
$1,000 invested in VIVS on Jul 31, 2025 (≈ 534.759357 VIVS) would be worth
$178.93
-$821.07 (-82.1%) today · 0.18× · US Dollar
Based on a VIVS entry price of $1.87 vs. today's $0.3346.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.42 | $796.67 | -20.3% |
| 1 month ago | $1.06 | $315.66 | -68.4% |
| 3 months ago | $1.44 | $232.36 | -76.8% |
| 6 months ago | $2.43 | $137.7 | -86.2% |
| 1 year ago | $1.87 | $178.93 | -82.1% |
| All time (5.0y) ago | $94.68 | $3.53 | -99.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VIVS forecast.
Our base-case forecast reaches $0.67 around 2050.
Implied market cap at $0.67: $2.34M
The multi-year forecast shows a path of mixed returns with an overall bullish tilt. For 2026, the avg is $0.3446 with a neutral sentiment and ROI of 0%. The 2027 outlook is bearish with an avg of $0.2812 and ROI of -18.4%.
The forecast improves from 2029 onward, with 2029 avg $0.5022 and ROI 45.8% and 2030 avg $0.4536 and ROI 31.6% as bullish. The 2040 projection remains bullish at an avg of $0.5421 and ROI 57.3%, and the 2050 forecast shows strong upside with an avg of $1.16 and ROI 235.5%, all labeled bullish. These figures imply meaningful upside potential by mid- to late decade with the path subject to volatility and risk.
Tap a question to reveal the answer.
2030 forecast: min $0.2812, avg $0.4536, max $0.7854; ROI 31.6%; sentiment BULLISH.
Forecasts show a mix of outcomes, including bearish years (e.g., 2027 with ROI -18.4%) and bullish years (e.g., 2029 with ROI 45.8% and 2050 with ROI 235.5%). These figures indicate risk alongside upside potential and are not guarantees.
The forecast max for 2050 is $2.66, with 2040 max $1.19 and 2035 max $1.11, suggesting the possibility of surpassing $1 by 2050 on the higher end of the forecast.
Current price is $0.3446 with a market cap of $1.2M, and rank 5483.
For 2026, min $0.34, avg $0.3446, max $0.4867; ROI 0%; sentiment NEUTRAL.
VivoSim Labs, Inc. Community Discussion
0Share your VivoSim Labs, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.